Cargando…
Circ_0110805 Knockdown Enhances Cisplatin Sensitivity and Inhibits Gastric Cancer Progression by miR-299-3p/ENDOPDI Axis
BACKGROUND: Gastric cancer is a prevalent primary stomach tumor. Cisplatin is frequently used to treat gastric cancer. However, the resistance of cisplatin in gastric cancer often occurs, which brings a heavy burden to gastric cancer treatment. METHODS: In this study, we revealed a novel underlying...
Autores principales: | Yang, Xi, Zhang, Qunxiong, Guan, Bugao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654533/ https://www.ncbi.nlm.nih.gov/pubmed/33192077 http://dx.doi.org/10.2147/OTT.S279563 |
Ejemplares similares
-
Knockdown of circ-PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR-429/FOXK1 signaling axis
por: Cao, Limin, et al.
Publicado: (2021) -
Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis
por: Wu, Zhihui, et al.
Publicado: (2020) -
circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer
por: Shi, Wenting, et al.
Publicado: (2022) -
Knockdown of lncRNA HCP5 Suppresses the Progression of Colorectal Cancer by miR-299-3p/PFN1/AKT Axis
por: Bai, Ni, et al.
Publicado: (2020) -
circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition
por: Liang, Qianping, et al.
Publicado: (2023)